Veriti Management LLC grew its stake in CME Group Inc. (NASDAQ:CME – Get Rating) by 3.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,183 shares of the financial services provider's stock after acquiring an additional 230 shares during the quarter. Veriti Management LLC's holdings in CME Group were worth $1,266,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Parkside Financial Bank & Trust increased its holdings in shares of CME Group by 15.9% in the 4th quarter. Parkside Financial Bank & Trust now owns 371 shares of the financial services provider's stock valued at $85,000 after acquiring an additional 51 shares during the period. Tiedemann Advisors LLC boosted its position in shares of CME Group by 0.3% in the 1st quarter. Tiedemann Advisors LLC now owns 19,681 shares of the financial services provider's stock worth $4,682,000 after purchasing an additional 53 shares in the last quarter. MJP Associates Inc. ADV boosted its position in shares of CME Group by 5.7% in the 2nd quarter. MJP Associates Inc. ADV now owns 983 shares of the financial services provider's stock worth $201,000 after purchasing an additional 53 shares in the last quarter. Insight Folios Inc boosted its position in shares of CME Group by 2.6% in the 2nd quarter. Insight Folios Inc now owns 2,148 shares of the financial services provider's stock worth $440,000 after purchasing an additional 55 shares in the last quarter. Finally, KC Investment Advisors LLC boosted its position in shares of CME Group by 1.7% in the 1st quarter. KC Investment Advisors LLC now owns 3,343 shares of the financial services provider's stock worth $795,000 after purchasing an additional 55 shares in the last quarter. 85.56% of the stock is currently owned by hedge funds and other institutional investors.
Get
CME Group alerts:
CME Group Trading Down 1.2 %
CME opened at $181.08 on Monday. The stock has a market capitalization of $65.09 billion, a PE ratio of 22.47, a P/E/G ratio of 2.92 and a beta of 0.40. CME Group Inc. has a one year low of $178.75 and a one year high of $256.94. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The business's 50 day moving average price is $198.09 and its 200 day moving average price is $209.96.
CME Group (NASDAQ:CME – Get Rating) last announced its quarterly earnings results on Wednesday, July 27th. The financial services provider reported $1.97 EPS for the quarter, beating the consensus estimate of $1.92 by $0.05. The business had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.25 billion. CME Group had a return on equity of 9.65% and a net
margin of 60.43%. The company's quarterly revenue was up 4.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.64 EPS. As a group, equities research analysts expect that CME Group Inc. will post 7.96 EPS for the current year.
CME Group Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 27th. Shareholders of record on Friday, September 9th will be given a dividend of $1.00 per share. This represents a $4.00 dividend on an annualized basis and a dividend yield of 2.21%. The ex-dividend date is Thursday, September 8th. CME Group's dividend payout ratio is presently 49.63%.
Analysts Set New Price Targets
A number of analysts have recently weighed in on CME shares. Morgan Stanley lowered their price objective on CME Group from $242.00 to $226.00 and set an "equal weight" rating for the company in a research report on Thursday, July 28th. Rosenblatt Securities began coverage on CME Group in a research report on Tuesday, August 16th. They set a "sell" rating and a $171.00 price target for the company. Jefferies Financial Group began coverage on CME Group in a research report on Tuesday, May 31st. They set a "buy" rating and a $267.00 price target for the company. Atlantic Securities raised CME Group from a "neutral" rating to an "overweight" rating and set a $235.00 price target for the company in a research report on Friday, June 10th. Finally, UBS Group lowered their price target on CME Group from $246.00 to $240.00 and set a "buy" rating for the company in a research report on Tuesday, August 2nd. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $230.80.
Insider Activity
In related news, insider Timothy Francis Mccourt sold 360 shares of CME Group stock in a transaction that occurred on Monday, September 19th. The shares were sold at an average price of $190.77, for a total value of $68,677.20. Following the completion of the sale, the insider now owns 5,431 shares in the company, valued at approximately $1,036,071.87. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, insider Ken Vroman sold 750 shares of CME Group stock in a transaction that occurred on Monday, September 12th. The shares were sold at an average price of $201.41, for a total value of $151,057.50. Following the completion of the transaction, the insider now owns 12,486 shares in the company, valued at $2,514,805.26. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Timothy Francis Mccourt sold 360 shares of CME Group stock in a transaction on Monday, September 19th. The shares were sold at an average price of $190.77, for a total value of $68,677.20. Following the completion of the transaction, the insider now owns 5,431 shares of the company's stock, valued at $1,036,071.87. The disclosure for this sale can be found here. In the last three months, insiders have sold 10,511 shares of company stock valued at $2,123,186. Company insiders own 0.30% of the company's stock.
CME Group Company Profile
(Get Rating)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.
Recommended Stories
- Get a free copy of the StockNews.com research report on CME Group (CME)
- Can Caterpillar Claw Higher in a Falling Market?
- Is Dave & Buster's Immune to High Inflation and Lower Spending?
- Should These 3 Top-Performing Mid-Caps Be On Your Watchlist?
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
